{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-087118","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2024-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.474143+00:00","generated_at":"2026-05-31T15:53:58.038540+00:00","sec_items":["2.03","1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Achieve Life Sciences enters $10M convertible debt agreement with Silicon Valley Bank, up to $20M total","bullets":["Initial $10M term loan funded July 25, 2024; up to $10M additional subject to FDA NDA acceptance and lender approval.","Interest at greater of 7.0% or prime minus 1.0%; interest-only until Dec 31, 2025; maturity Dec 1, 2027 (extendable to Jun 1, 2028).","Conversion rights: initial conversion price $7.00/share, up to 1.43M shares; subsequent tranches at higher of $4.854 or 150% of trailing 10-day VWAP.","Refinanced prior 2023 convertible debt of $16.6M; obligations satisfied and terminated.","Registration rights granted to lender for resale of conversion shares."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-087118","json":"https://secwatch.observer/filing/0000950170-24-087118.json","markdown":"https://secwatch.observer/filing/0000950170-24-087118.md","text":"https://secwatch.observer/filing/0000950170-24-087118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000095017024087118/0000950170-24-087118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000095017024087118/achv-20240725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:53:58.038540+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}